Clinical Trials | April 22, 2026
Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease
By cutting pain crises & boosting haemoglobin
By cutting pain crises & boosting haemoglobin
It is actually a new ISO Class 5 controlled cleanroom designed to deliver washed, dried, and gamma-sterilized single-use assemblies ready for immediate use.
If approved, the move would significantly broaden the use of KEYTRUDA and KEYTRUDA QLEX in combination with Padcev
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Experts highlighted how robotic-assisted procedures are improving surgical precision, reducing complications, and enabling faster recovery
Subscribe To Our Newsletter & Stay Updated
